Table 3.
Quality of life of HIV-infected patients included in study and with lipodystrophy compared with no lipodystrophy.
| Domains SF-36 | HIV-infected patients | Lipodystrophy group | No lipodystrophy group |
|---|---|---|---|
| Functional capacity | 71.1 ± 25.4 | 61.76 ± 24.02* | 77.76 ± 24.03 |
| Physical limitation | 81.4 ± 20.8 | 80.15 ± 33.58 | 82.76 ± 27.63 |
| Pain | 42.3 ± 9.5 | 43.18 ± 8.58 | 41.24 ± 10.56 |
| General health | 61.0 ± 20.6 | 62.35 ± 18.97 | 59.41 ± 22.64 |
| Vitality | 58.0 ± 15.6 | 58.97 ± 14.86 | 56.90 ± 16.71 |
| Social aspects | 80.6 ± 21.2 | 81.31 ± 19.82 | 79.36 ± 22.72 |
| Emotional limitation | 78.2 ± 33.8 | 78.04 ± 34.10 | 78.30 ± 34.07 |
| Mental health | 60.2 ± 12.9 | 62.47 ± 11.22 | 57.52 ± 14.47 |
*
p < 0.01 versus no lipodystrophy group.